N-methylated sst 2 selective somatostatin cyclic peptide analogue as a potent candidate for treating neurogenic inflammation

Jayanta Chatterjee, Burkhardt Laufer, Johannes G. Beck, Zsuzsanna Helyes, Erika Pintér, János Szolcsányi, Aniko Horvath, Jozsef Mandl, Jean C. Reubi, György Kéri, Horst Kessler

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

A focused multiply N-methylated library of a cyclic hexapeptidic somatostatin analogue: MK678 cyclo(-MeAYwKVF-) was generated, which resulted in the unexpected observation of an efficacious tetra-N-methylated analogue, cyclo(-MeAYMewMeKVMeF-) with a potent inhibitory action on sensory neuropeptide release in vitro and on acute neurogenic inflammatory response in vivo. The analogue shows selectivity toward somatostatin receptor subtype 2 (sst 2). Extensive 2D NMR spectroscopy and molecular dynamics simulation revealed the solution conformation of the analogue, which can be adopted as a lead for the further structure-activity relationship studies targeting neurogenic inflammation.

Original languageEnglish
Pages (from-to)509-514
Number of pages6
JournalACS Medicinal Chemistry Letters
Volume2
Issue number7
DOIs
StatePublished - 14 Jul 2011

Keywords

  • N-methylated peptide
  • Somatostatin
  • cyclic peptide
  • multiple N-methylation
  • neurogenic inflammation
  • sst

Fingerprint

Dive into the research topics of 'N-methylated sst 2 selective somatostatin cyclic peptide analogue as a potent candidate for treating neurogenic inflammation'. Together they form a unique fingerprint.

Cite this